Johnson & Johnson
Johnson & Johnson MedTech, a global leader in heart recovery, showcased the latest long-term survival data confirming the Impella CP's survival benefit and presented the newest Impella innovations during the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. The Impella heart pump, the world's smallest, is
Bortezomib
Researchers have published a study on the treatment-emergent peripheral neuropathy associated with bortezomib-based frontline regimens for multiple myeloma. The study found that patients receiving bortezomib-based treatments experienced a significantly higher incidence of treatment-emergent peripheral neuropathy (TEPN) compared to those receiving non-bortezomib-based treatments. The study's authors emphasized the need
Abiomed Inc.
Recent novel data presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference highlighted the safety and survival benefits of Abiomed's Impella heart pump technology in high-risk percutaneous coronary intervention (PCI) and cardiogenic shock patients. The data, which include results from a randomized controlled trial (RCT) published in the
Vaccines
Walmart and Sam's Club pharmacies are preparing to administer COVID-19 booster shots, now authorized for Moderna and Johnson & Johnson (J&J) vaccines, following the Centers for Disease Control and Prevention's (CDC) announcement. As the initial COVID-19 vaccines become less effective over time, booster shots
Vaccines
The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) has welcomed the recommendations by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to approve booster shots of the Moderna and Janssen (Johnson and Johnson) COVID-19 vaccines for long-term care
COVID-19 vaccines
The Philippines has matched Mexico and Hungary's record by issuing six Emergency Use Authorizations (EUAs) for Covid-19 vaccines. According to FDA Director General Eric Domingo, the country has similarly authorized six Covid-19 vaccines, including those from Pfizer-Biontech, AstraZeneca, Gamaleya Research Institute of Epidemiology, and Sinovac Biotech. Despite concerns
COVID-19 vaccines
Public health experts worry that the pause on administering the Johnson & Johnson COVID-19 vaccine will hinder efforts to reach marginalized, vulnerable populations, including communities of color. The one-and-done nature of the J&J COVID-19 shot and less stringent storage requirements made it ideal for homebound people, those in
Johnson & Johnson
The US Department of Veterans Affairs has decided to temporarily halt the administration of the Johnson & Johnson (Janssen) COVID-19 vaccine due to concerns raised by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA). This precautionary measure prioritizes the safety of veterans,
Johnson & Johnson
Ohio State University's Wexner Medical Center has administered over 163,000 COVID-19 vaccine doses since December 14, with only 1,116 being the Johnson and Johnson/Janssen (JandJ) vaccine. The pause in the use of the JandJ vaccine was announced by the U.S. Food and Drug Administration
COVID-19 vaccines
Christopher Rowland, an executive at Emergent BioSolutions, the troubled manufacturer at the heart of Johnson & Johnson's coronavirus vaccine production problems, received a 51 percent increase in total compensation in 2020, to $5.6 million, according to a public filing. The company's annual proxy disclosure said
COVID-19 vaccines
The Maine Department of Health and Human Services (DHHS) announced that the Maine Center for Disease Control and Prevention (Maine CDC) is preparing to receive 36,690 doses of COVID-19 vaccine for the 18th week of distribution, starting April 12. This is a decrease of 18,100 doses from the
Vaccination
As the COVID-19 pandemic continues to affect communities across the United States, the U.S. Department of Homeland Security (DHS) has made significant progress in vaccinating its workforce through Operation Vaccinate Our Workforce (Operation VOW). In just two months, Operation VOW has vaccinated over 58,000 DHS mission-critical 1A and
